Loading organizations...
§ Private Profile · Basel, Basel-Stadt, Switzerland
Biotechnology company developing thymus-rejuvenating biologics.
TECregen has raised $12.5M across 1 funding round.
TECregen has raised $12.5M in total across 1 funding round.
TECregen has raised $12.5M across 1 funding round. Most recently, it raised $12.5M Seed in January 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 8, 2026 | $12.5M Seed | Philipp Mueller | Carma Fund, EOS Bioinnovation, High Tech Grunderfonds, JFG Life Sciences Foundation, Lifespan Vision Ventures, Zürcher Kantonalbank | Announced |
TECregen has raised $12.5M in total across 1 funding round.
TECregen's investors include Philipp Mueller, Carma Fund, Eos Bioinnovation, High-Tech Grunderfonds, JFG Life Sciences Foundation, LifeSpan Vision Ventures, Zürcher Kantonalbank.